These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34414957)
1. A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma. Li Q; Fan B; Ding J; Xiang X; Zhang J Medicine (Baltimore); 2021 Aug; 100(33):e26948. PubMed ID: 34414957 [TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma. Chen W; Ou M; Tang D; Dai Y; Du W J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443 [TBL] [Abstract][Full Text] [Related]
3. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
4. Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis. Lei J; Zhang D; Yao C; Ding S; Lu Z Cancer Control; 2020; 27(1):1073274820977114. PubMed ID: 33269615 [TBL] [Abstract][Full Text] [Related]
5. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis. Xing M; Li J Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724 [TBL] [Abstract][Full Text] [Related]
6. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387 [TBL] [Abstract][Full Text] [Related]
7. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
8. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
9. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma. Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352 [TBL] [Abstract][Full Text] [Related]
10. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma. Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285 [TBL] [Abstract][Full Text] [Related]
11. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
12. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma. Li L; Xia S; Shi X; Chen X; Shang D Sci Rep; 2021 May; 11(1):10728. PubMed ID: 34021184 [TBL] [Abstract][Full Text] [Related]
13. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Liu Z; Yang L; Liu C; Wang Z; Xu W; Lu J; Wang C; Xu X Front Immunol; 2024; 15():1371829. PubMed ID: 38933262 [TBL] [Abstract][Full Text] [Related]
16. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. Gao YJ; Li SR; Huang Y Front Oncol; 2023; 13():1118152. PubMed ID: 36969014 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
18. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471 [TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
20. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]